SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hess Corporation (HES) trades at a trailing P/E of 16.6, forward P/E of 17.9. Trailing earnings yield is 6.03%, forward earnings yield 5.60%. PEG 0.17 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (71/100, Pass) — P/E is below market average (16.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.17); earnings yield beats bond yields (6.03%).
- PEG Ratio 0.17 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 6.03% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $163.00 (+9.4% upside) — modest upside expected.
Overall SharesGrow Score: 78/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
71/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HES
Valuation Multiples
P/E (TTM)16.6
Forward P/E17.9
PEG Ratio0.17
Forward PEG0.62
P/B Ratio0.00
P/S Ratio3.56
EV/EBITDA0.0
Per Share Data
EPS (TTM)$8.98
Forward EPS (Est.)$8.34
Book Value / Share$0.00
Revenue / Share$41.83
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.03%
Forward Earnings Yield5.60%
Dividend Yield0.00%
Analyst Target$163.00 (+9.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-10.78 |
$6.64B |
$-3.06B |
-46.1% |
| 2016 |
$-19.79 |
$4.76B |
$-6.13B |
-128.8% |
| 2017 |
$-12.97 |
$5.47B |
$-4.07B |
-74.5% |
| 2018 |
$-0.95 |
$6.33B |
$-282M |
-4.5% |
| 2019 |
$-0.80 |
$6.5B |
$-240M |
-3.7% |
| 2020 |
$-10.15 |
$4.67B |
$-3.09B |
-66.3% |
| 2021 |
$1.80 |
$7.47B |
$559M |
7.5% |
| 2022 |
$6.77 |
$11.32B |
$2.1B |
18.5% |
| 2023 |
$4.49 |
$10.51B |
$1.38B |
13.1% |
| 2024 |
$8.98 |
$12.9B |
$2.77B |
21.5% |
